Deepak Nitrite Q4 Results Review - Healthy Outlook For Phenolics Business Over FY24/FY25: Dolat Capital

BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy. .Dolat Capital Report.Deepak Nitrite Ltd.'s Q4 FY23 numbers were broadly in line with our estimates. Sales grew by 4.8% YoY to Rs 19.6 billion (our estimate: Rs 20.4 billion) (down 1.5% sequentially).Ebitda de-grew by 15.2% YoY to Rs 3.5 billion (up 10.6% QoQ) (our estimate: Rs 3.6 billion) impacted by higher opex cost (up 22.4% YoY). Deepak Nitrite's profit after tax saw a de-growth of 12.5% YoY (up 11.9% QoQ) to Rs 2.3 billion (our estimate: Rs 2.4 billion).Timely execution of its capex projects and their speedy ramp up will remain a key to its growth in the near to medium term. We believe that entry into value added downstream derivatives, advanced chemistries and forward integration into Polycarbonates will help the company to subside the cyclicality in its business. We however remain cautious of the near term recessionary trends and thus have downward revised our estimates marginally..Click on the attachment to read the full report:.SRF Q4 Results Review - Chemicals Business To Grow At 20% Plus In FY24E: Centrum Broking.DISCLAIMERThis report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime..Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Deepak Nitrite Q4 Results Review - Healthy Outlook For Phenolics Business Over FY24/FY25: Dolat Capital

Capex of about Rs 25 billion over FY23-FY25 to drive future growth.

Choose a plan